|
1
|
World Health Organization (WHO). Obesity
and overweight. http://www.who.int/mediacentre/factsheets.
Accessed 22 May, 2012
|
|
2
|
Utian WH, Archer DF, Bachmann GA,
Gallagher C, Grodstein F, Heiman JR, et al: Estrogen and
progestogen use in postmenopausal women: July 2008 position
statement of The North American Menopause Society. Menopause.
15:584–602. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gouveia DA, Bahamondes L, Aldrighi JM,
Tamanaha S, Ribeiro AL and Aoki T: Prevalence of endometrial injury
in asymptomatic obese women. Rev Assoc Med Bras. 53:344–348.
2007.(In Portuguese).
|
|
4
|
Dreisler E, Stampe Sorensen S, Ibsen PH
and Lose G: Prevalence of endometrial polyps and abnormal uterine
bleeding in a Danish population aged 20–74 years. Ultrasound Obstet
Gynecol. 33:102–108. 2009.
|
|
5
|
Baiocchi G, Manci N, Pazzaglia M, Giannone
L, Burnelli L, Giannone E, et al: Malignancy in endometrial polyps:
A 12-year experience. Am J Obstet Gynecol. 201:462.e1–4.
2009.PubMed/NCBI
|
|
6
|
Lieng M, Istre O, Sandvik L and Qvigstad
E: Prevalence, 1-year regression rate, and clinical significance of
asymptomatic endometrial polyps: cross-sectional study. J Minim
Invasive Gynecol. 16:465–471. 2009.PubMed/NCBI
|
|
7
|
Sant’Ana de Almeida EC, Nogueira AA,
Candido dos Reis FJ, Zambelli Ramalho LN and Zucoloto S:
Immunohistochemical expression of estrogen and progesterone
receptors in endometrial polyps and adjacent endometrium in
postmenopausal women. Maturitas. 49:229–233. 2004.
|
|
8
|
Soliman PT, Wu D, Tortolero-Luna G,
Schmeler KM, Slomovitz BM, Bray MS, Gerhenson DM and Lu KH:
Association between adiponectin, insulin resistance, and
endometrial cancer. Cancer. 106:2376–2381. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oguz S, Sargin A, Kelekci S, Aytan H,
Tapisiz OL and Mollamahmutoglu L: The role of hormone replacement
therapy in endometrial polyp formation. Maturitas. 50:231–236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Onalan R, Onalan G, Tonguc E, Ozdener T,
Dogan M and Mollamahmutoglu L: Body mass index is an independent
risk factor for the development of endometrial polyps in patients
undergoing in vitro fertilization. Fertil Steril. 91:1056–1060.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Belisário MS, Vassallo J, Andrade L,
Alvarenga M, Pinto GA and Monteiro IM: The expression of the
hormone receptors in the endometrium and endometrial polyps in
postmenopausal women and its relationship to body mass index.
Maturitas. 53:114–118. 2006.PubMed/NCBI
|
|
12
|
McGurgan P, Taylor LJ, Duffy SR and
O’Donovan PJ: An immunohistochemical comparison of endometrial
polyps from postmenopausal women exposed and not exposed to HRT.
Maturitas. 53:454–461. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Risberg B, Karlsson K, Abeler V, Lagrelius
A, Davidson B and Karlsson MG: Dissociated expression of Bcl-2 and
Ki-67 in endometrial lesions: diagnostic and histogenic
implications. Int J Gynecol Pathol. 21:155–160. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tokyol C, Aktepe F, Dilek FH, Sahin O and
Arioz DT: Expression of cyclooxygenase-2 and matrix
metalloproteinase-2 in adenomyosis and endometrial polyps and its
correlation with angiogenesis. Int J Gynecol Pathol. 28:148–156.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maia H Jr, Pimentel K, Silva TM, Freitas
LA, Zausner B, Athayde C, et al: Aromatase and cyclooxygenase-2
expression in endometrial polyps during the menstrual cycle.
Gynecol Endocrinol. 22:219–224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao J, Tian J, Lv Y, Shi F, Kong F, Shi H,
et al: Leptin induces functional activation of cyclooxygenase-2
through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human
endometrial cancer cells. Cancer Sci. 100:389–395. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gregoriou O, Konidaris S, Vrachnis N,
Bakalianou K, Salakos N, Papadias K, Kondi-Pafiti A and Creatsas G:
Clinical parameters linked with malignancy in endometrial polyps.
Climacteric. 12:454–458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Costa-Paiva L, Godoy CE Jr, Antunes A Jr,
Caseiro JD, Arthuso M and Pinto-Neto AM: Risk of malignancy in
endometrial polyps in premenopausal and postmenopausal women
according to clinicopathologic characteristics. Menopause.
18:1278–1282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Harvey JM, Clark GM, Osborne CK and Allred
DC: Estrogen receptor status by immunohistochemistry is superior to
the ligand-binding assay for predicting response to adjuvant
endocrine therapy in breast cancer. J Clin Oncol. 17:1474–1481.
1999.PubMed/NCBI
|
|
20
|
Stuart-Harris R, Caldas C, Pinder SE and
Pharoah P: Proliferation markers and survival in early breast
cancer: a systematic review and meta-analysis of 85 studies in
32,825 patients. Breast. 17:323–334. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dowsett M, Nielsen TO, A’Hern R, Bartlett
J, Coombes RC, Cuzick J, et al: Assessment of Ki67 in breast
cancer: recommendation from the International Ki67 in Breast Cancer
working group. J Natl Cancer Inst. 103:1656–1664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lopes RG, Baracat EC, de Albuquerque Neto
LC, Ramos JF, Yatabe S, Depesr DB, et al: Analysis of estrogen- and
progesterone-receptor expression in endometrial polyps. J Minim
Invasive Gynecol. 14:300–303. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gul A, Ugur M, Iskender C, Zulfikaroglu E
and Ozaksit G: Immunohistochemical expression of estrogen and
progesterone receptors in endometrial polyps and its relationship
to clinical parameters. Arch Gynecol Obstet. 281:479–483. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Villavicencio A, Aguilar G, Argüello G,
Dünner C, Gabler F, Soto E, et al: The effect of overweight and
obesity on proliferation and activation of AKT and ERK in human
endometria. Gynecol Oncol. 117:96–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Inceboz US, Nese N, Uyar Y, Ozcakir HT,
Kurtul O, Baytur YB, et al: Hormone receptor expressions and
proliferation markers in postmenopausal endometrial polyps. Gynecol
Obstet Invest. 61:24–28. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McGurgan P, Taylor LJ, Duffy SR and
O’Donovan PJ: Are endometrial polyps from pre-menopausal women
similar to postmenopausal women? An immunohistochemical comparison
of endometrial polyps from pre- and post-menopausal women.
Maturitas. 54:277–284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taylor LJ, Jackson TL, Reid JG and Duffy
SR: The differential expression of oestrogen receptors,
progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. BJOG.
110:794–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amalinei C, Cianga C, Balan R, Cianga P,
et al: Immunohistochemical analysis of steroid receptors,
proliferation markers, apoptosis related molecules, and gelatinases
in non-neoplastic and neoplastic endometrium. Ann Anat. 193:43–55.
2011. View Article : Google Scholar
|
|
29
|
Erdemoglu E, Güney M, Karahan N and Mungan
T: Expression of cyclooxygenase-2, matrix metalloproteinase-2 and
matrix metalloproteinase-9 in premenopausal and postmenopausal
endometrial polyps. Maturitas. 59:268–274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nishimura S, Manabe I and Nagai R: Adipose
tissue in obesity and metabolic syndrome. Discov Med. 8:55–60.
2009.
|
|
31
|
Byers T and Sedjo RL: Does intentional
weight loss reduce cancer risk? Diabetes Obes Metab. 13:1063–1072.
2011. View Article : Google Scholar : PubMed/NCBI
|
